| Literature DB >> 30355619 |
Anne Monks1, Yingdong Zhao2, Curtis Hose1, Hossein Hamed2, Julia Krushkal2, Jianwen Fang2, Dmitriy Sonkin2, Alida Palmisano2, Eric C Polley3, Laura K Fogli3, Mariam M Konaté3, Sarah B Miller3, Melanie A Simpson4, Andrea Regier Voth4, Ming-Chung Li2, Erik Harris1, Xiaolin Wu5, John W Connelly1, Annamaria Rapisarda1, Beverly A Teicher3, Richard Simon2, James H Doroshow6,7.
Abstract
: The intracellular effects and overall efficacies of anticancer therapies can vary significantly by tumor type. To identify patterns of drug-induced gene modulation that occur in different cancer cell types, we measured gene-expression changes across the NCI-60 cell line panel after exposure to 15 anticancer agents. The results were integrated into a combined database and set of interactive analysis tools, designated the NCI Transcriptional Pharmacodynamics Workbench (NCI TPW), that allows exploration of gene-expression modulation by molecular pathway, drug target, and association with drug sensitivity. We identified common transcriptional responses across agents and cell types and uncovered gene-expression changes associated with drug sensitivity. We also demonstrated the value of this tool for investigating clinically relevant molecular hypotheses and identifying candidate biomarkers of drug activity. The NCI TPW, publicly available at https://tpwb.nci.nih.gov, provides a comprehensive resource to facilitate understanding of tumor cell characteristics that define sensitivity to commonly used anticancer drugs. SIGNIFICANCE: The NCI Transcriptional Pharmacodynamics Workbench represents the most extensive compilation to date of directly measured longitudinal transcriptional responses to anticancer agents across a thoroughly characterized ensemble of cancer cell lines. ©2018 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30355619 PMCID: PMC6295263 DOI: 10.1158/0008-5472.CAN-18-0989
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701